Carisma Therapeutics
Philadelphia, US · Founded 2017 · Delaware corporation · 7 known investors
Biotech
Founders & leadership
SK
Steven KellyExecutive Officer, Director
MC
Margarita ChavezDirector
EN
Eran NadavDirector
AS
Althea StillmanDirector
JG
Jacob GunterbergDirector
RH
Regina HoditsDirector
Investors · 7
Reported raises · per SEC filings
Form D private placements▶$38.3MraisedJan 2021 · 13 investors · BiotechnologyRule 506(b)
▶$38.3MraisedJan 2021 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Briggs MorrisonDirector
- Jacob GunterbergDirector
- Regina HoditsDirector
- Michael HeffernanDirector
- Chidozie UgwumbaDirector
- Margarita ChavezDirector
- Steven KellyExecutive Officer, Director
- Offering amount
- $70.4M
- Amount sold
- $38.3M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$52.9MraisedJul 2020 · 11 investors · BiotechnologyRule 506(b)
▶$52.9MraisedJul 2020 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven KellyExecutive Officer, Director
- Margarita ChavezDirector
- Eran NadavDirector
- Althea StillmanDirector
- Jacob GunterbergDirector
- Regina HoditsDirector
- Offering amount
- $52.9M
- Amount sold
- $52.9M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3.9MraisedApr 2018 · 7 investors · BiotechnologyRule 506(b)
▶$3.9MraisedApr 2018 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Margarita ChavezDirector
- Steven KellyExecutive Officer, Director
- Bruce PeacockDirector
- Michael PoiselDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.